Le Lézard
Classified in: Health
Subject: PER

Robert E. Abernathy Joins Haemonetics Board of Directors


BRAINTREE, Mass., Oct. 18, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Robert E. Abernathy, a seasoned healthcare executive, to its Board of Directors. Mr. Abernathy has led major medical businesses in North America and Europe with Halyard Health, Inc.

HAE logo April 2016.

Richard J. Meelia, Chairman of Haemonetics' Board of Directors commented: "Robert Abernathy brings us extensive experience in the healthcare industry and in international operations, with in-depth knowledge of the needs of healthcare providers and patients. We welcome him and look forward to his contribution to our Company's success."

Mr. Abernathy served as Chairman of the Board of Directors and Chief Executive Officer of Halyard Health, Inc., a Kimberly-Clark Corporation spinoff medical technology company specializing in important patient health care needs. Over 35 previous years, his positions of increasing responsibility included President of Kimberly-Clark's Global Health Care business; Group President, Developing & Emerging Markets; Managing Director, Kimberly-Clark Australia and President, North Atlantic Consumer Products.

Mr. Abernathy previously served on the Board of Directors of The Advanced Medical Technology Association (AdvaMed). He earned a Bachelor of Science degree in chemistry from the University of Alabama and a Master's of Science degree in paper chemistry from the Institute of Paper Chemistry at Lawrence University.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.         

CONTACT:
Gerry Gould, VP-Investor Relations
(781) 356-9402
[email protected]

SOURCE Haemonetics Corporation


These press releases may also interest you

at 13:24
Susan G. Komen®, the world's leading breast cancer organization, applauds Representative Patty Acomb (D-Minnetonka) for introducing legislation that would eliminate financial barriers to clinically appropriate genetic testing, as well as the...

at 13:16
Risas Dental & Braces ("Risas"), a dental and braces provider that serves patients in Arizona, Colorado, Texas, and Nevada, has learned of a data security incident that may have involved the protected health information of certain Risas patients....

at 13:15
The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering. As of 2022, the global long-acting drug delivery technologies and services...

at 13:15
The "Global Organoids And Spheroids Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global organoids and spheroids market size was estimated to be USD 0.781 billion in 2023 and is anticipated...

at 13:05
Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, today reported...

at 13:00
The following is written by Dr. Steven Gonzales, Chancellor, Maricopa Community Colleges, a member of the American Association of Community Colleges: Arizona, like many states across America, is facing a nurse shortage.  The pandemic has taken a toll...



News published on and distributed by: